Risk factors for stroke and thromboprophylaxis in atrial fibrillation: What happens in daily clinical practice? The GEFAUR-1 study

Annals of Emergency Medicine

Volumn 44, Issue 1, 2004, Pages 3-11

  Laguna, Pedro ^a   Martín, Alfonso ^b   Del Arco, Carmen ^a   Gargantilla, Pedro ^a  

^a Scientific Committee   (Spain)

^b HOSPITAL DE MÓSTOLES   (Spain)

Author keywords

[No Author keywords available]

Indexed keywords

ANTICOAGULANT AGENT; LOW MOLECULAR WEIGHT HEPARIN; WARFARIN;

ADULT; AGED; ANTICOAGULANT THERAPY; ANTICOAGULATION; ARTICLE; CARDIOVASCULAR RISK; CLINICAL EXAMINATION; CLINICAL PRACTICE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DIABETES MELLITUS; DRUG CONTRAINDICATION; DRUG INDICATION; EMBOLISM; EMERGENCY TREATMENT; EMERGENCY WARD; FEMALE; HEART ATRIUM FIBRILLATION; HEART DISEASE; HEART FAILURE; HUMAN; HYPERTENSION; MAJOR CLINICAL STUDY; MALE; MULTICENTER STUDY; NEUROPROTECTION; PREVALENCE; PRIORITY JOURNAL; RISK ASSESSMENT; RISK FACTOR; STROKE; THROMBOSIS PREVENTION; TREATMENT INDICATION;

AGED; ANTICOAGULANTS; ATRIAL FIBRILLATION; CEREBROVASCULAR ACCIDENT; CROSS-SECTIONAL STUDIES; DRUG UTILIZATION; EMERGENCY SERVICE, HOSPITAL; FEMALE; GUIDELINE ADHERENCE; HUMANS; MALE; PHYSICIAN'S PRACTICE PATTERNS; PRACTICE GUIDELINES; RISK FACTORS; SPAIN;

EID: 3042760827     PISSN: 01960644     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.annemergmed.2004.01.010     Document Type: Article

References (29)

1. Go A.S., Hylek E.M., Phillips K.A., et al. Prevalence of diagnosed atrial fibrillation in adults: national implications for rhythm management and stroke prophylaxis: the Anticoagulation and Risk Factors In Atrial Fibrillation (ATRIA) Study. JAMA. 285:2001;2370-2375
2. Atrial Fibrillation Investigators. Risk factors for stroke and efficacy of antithrombotic therapy in atrial fibrillation: analysis of pooled data from five randomized controlled trials. Arch Intern Med. 154:1994;1449-1457
3. Hart R.G., Benavente O., McBride R., et al. Antithrombotic therapy to prevent stroke in patients with atrial fibrillation: a meta-analysis. Ann Intern Med. 131:1999;492-501
4. Bungard T.J., Ghali W.A., Teo K.K., et al. Why do patients with atrial fibrillation not receive warfarin? Arch Intern Med. 160:2000;41-46
5. Fatovich D.M. Emergency medicine: recent developments. BMJ. 324:2002;958-962
6. Magnusson G. The hospital emergency department as the primary source of medical care. Scand J Soc Med. 8:1980;149-156
7. Brown E.M., Goel V. Factors related to emergency department use: results from the Ontario Heath Survey 1990. Ann Emerg Med. 24:1994;1083-1091
8. Martín A., Laguna P., Del Arco C., et al., on behalf of the GEFAUR investigators. The Spanish Atrial Fibrillation in Emergency Medicine Study Group (GEFAUR): background, aims and design of a prospective multicenter study of atrial fibrillation in hospital emergency departments. Emergencias. 13:2001;235-240
9. Laupacis A., Albers G., Dalen J., et al. Antithrombotic therapy in atrial fibrillation. Chest. 114:1998;579S-589S
10. Villar F., Banegas J.R., De Mata J., et al. Situation of cardiovascular diseases in Spain. Rev Clin Esp. 203:(Suppl 1):2003;2-5
11. American Heart Association Committee on Electrocardiography. Recommendations for standarization of leads and specifications for instruments in electrocardiography and vectocardiography. Circulation. 35:1967;583-602
12. Levy S., Novella P., Ricard P., et al. Paroxismal atrial fibrillation: a need for classification. J Cardiovasc Electrophysiol. 6:1995;69-74
13. Benjamin E.J., Levy D., Vaziri S.M., et al. Independent risk factors for atrial fibrillation in a population-based cohort: the Framingham Heart Study. JAMA. 271:1994;840-844
14. Fuster V., Ryden L.E., Asinger R.W., et al. ACC/AHA/ESC guidelines for the management of patients with atrial fibrillation: executive summary: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines and the European Society of Cardiology Committee for Practice Guidelines and Policy Conferences (Committee to Develop Guidelines for the Management of Patients with Atrial Fibrillation). Circulation. 104:2001;2118-2150
15. Katz S., Ford A.B., Moskowitz R.W., et al. Studies of illness in the aged: the index of ADL: a standardized measure of biological and psychosocial function. JAMA. 185:1963;914-919
16. Martín A., Merino J.L., Del Arco C., et al. Consensus document for the management of patients with atrial fibrillation in hospital emergency departments. Rev Esp Cardiol. 56:2003;801-816
17. Thomson R., McElroy H., Sudlow M. Guidelines on anticoagulant treatment in atrial fibrillation in Great Britain: variation in content and implications for treatment. BMJ. 316:1998;509-513
18. Scott P.A., Pancioli A.M., Davis L.A., et al. Prevalence of atrial fibrillation and antithrombotic prophylaxis in emergency department patients. Stroke. 33:2002;2664-2669
19. Balanzó X., Pujol R. A multicentric study of emergencies in basic general hospitals in Catalonia. Intercomarcal Internal Medicine Group. Med Clin (Barc). 92:1989;86-90
20. Munschauer F.E., Priore R.L., Hens M., et al. Thromboembolism prophylaxis in chronic atrial fibrillation: practice patterns in community and tertiary-care hospitals. Stroke. 28:1997;72-76
21. Sudlow M., Thomson R., Thwaites B., et al. Prevalence of atrial fibrillation and eligibility for anticoagulants in the community. Lancet. 352:1998;1167-1171
22. Gurwitz J.H., Monette J., Rochon P.A., et al. Atrial fibrillation and stroke prophylaxis with warfarin in the long-term care setting. Arch Intern Med. 157:1997;978-984
23. Albers G.W., Dalen J.E., Laupacis A., et al. Antithrombotic therapy in atrial fibrillation. Chest. 119:2001;194S-206S
24. Levine M.N., Raskob G., Landefeld S., et al. Hemorrhagic complications of anticoagulant treatment. Chest. 119:2001;108S-121S
25. Gottlieb L.K., Salem-Schatz S. Anticoagulation in atrial fibrillation: does efficacy in clinical trials translate into effectiveness in practice? Arch Intern Med. 154:1994;1945-1953
26. Evans A., Kalra L. Are the results of randomized controlled trials on anticoagulation in patients with atrial fibrillation generalizable to clinical practice? Arch Intern Med. 161:2001;1443-1447
27. Rodgers H., Sudlow M., Dobson R., et al. Warfarin anticoagulation in primary care: a regional survey of present practice and clinicians' views. Br J Gen Pract. 47:1997;309-310
28. Hylek E.M., Singer D.E. Risk factors for intracranial hemorrhage in outpatients taking warfarin. Ann Intern Med. 120:1994;897-902
29. Fihn S.D., Callahan C.M., Martin D.C., et al., for the National Consortium of Anticoagulation. The risk for and severity of bleeding complications in elderly patients treated with warfarin. Ann Intern Med. 124:1996;970-979